Rating History for Protagonist Therapeutics (PTGX) by Barclays

More Stocks Rated by Barclays | Latest Ratings for PTGX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/18/2026 Etzer Darout Maintain Overweight
(N/A)		 119.00
(113.00)		  
 		   Details